Dermatitis

The Wound Pros Launches Wound Care Without Walls Program in Nigeria

Retrieved on: 
Monday, March 4, 2024

LOS ANGELES, March 4, 2024 /PRNewswire/ -- Dr. Chris Otiko, co-founder and corporate treasurer at The Wound Pros: https://www.thewoundpros.com, was recently in Abuja, Nigeria's capital, to launch the company's Wound Care Without Walls (WCWW) program and introduce Tetracyte.

Key Points: 
  • The Wound Pros extends its healing services into Nigeria.
  • Promotes Tetracyte product
    LOS ANGELES, March 4, 2024 /PRNewswire/ -- Dr. Chris Otiko, co-founder and corporate treasurer at The Wound Pros: https://www.thewoundpros.com , was recently in Abuja, Nigeria's capital, to launch the company's Wound Care Without Walls (WCWW) program and introduce Tetracyte.
  • Otiko was accompanied by Texas resident Adebola Adefuye, clinical supervisor for The Wound Pros' Complex Wound Management Team.
  • Otiko and Adebola also had strategy discussions with Wound Pros employees in Nigeria, focusing on marketing avenues to launch product sales in Nigeria.

TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor

Retrieved on: 
Monday, February 26, 2024

NANJING, China and GAITHURSBURG, Md., Feb. 26, 2024 /PRNewswire/ -- TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced the initiation of IND-enabling studies for TT-02332, a potent, selective and highly CNS-penetrating NLRP3 inflammasome inhibitor.

Key Points: 
  • NANJING, China and GAITHURSBURG, Md., Feb. 26, 2024 /PRNewswire/ -- TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced the initiation of IND-enabling studies for TT-02332, a potent, selective and highly CNS-penetrating NLRP3 inflammasome inhibitor.
  • Over the past three years, we have achieved breakthroughs with the NLRP3 inhibitor program."
  • "Our clinical candidate compound TT-02332 is a highly potent NLRP3 inhibitor that has shown promising efficacy in a number of disease-relevant in vivo animal models.
  • TT-02332 demonstrates an excellent safety profile in recently completed repeated-dose toxicity studies in two animal species (Dose finding toxicity studies).

Why is skin disease often misdiagnosed and untreated in Black patients?

Retrieved on: 
Wednesday, February 21, 2024

For most of history, medical students studying dermatology have been shown pictures of diseases on white skin only, leading to vast inequities in how Black and brown people are treated for skin disorders.

Key Points: 
  • For most of history, medical students studying dermatology have been shown pictures of diseases on white skin only, leading to vast inequities in how Black and brown people are treated for skin disorders.
  • He founded AHS' dermatology division in 2020 and focuses on diseases that more commonly affect Black and Latinx populations.
  • Clark was in residency training when he noticed Black patients coming in with treatable diseases – sometimes covering 90 percent of their skin – that had gone untreated and undiagnosed.
  • "Someone who's not familiar with what that looks like in Black skin may say, 'Oh this is mild,'" Clark said.

Golden State Dermatology Announces New Torrance Partnership

Retrieved on: 
Wednesday, February 21, 2024

TORRANCE, Calif., Feb. 21, 2024 /PRNewswire/ -- Golden State Dermatology (GSD) is pleased to announce a new partnership with Shirlene Jay, MD, and her team in Torrance. This new practice expands the GSD Network as the fourth location in the Greater Los Angeles Area.

Key Points: 
  • TORRANCE, Calif., Feb. 21, 2024 /PRNewswire/ -- Golden State Dermatology (GSD) is pleased to announce a new partnership with Shirlene Jay, MD, and her team in Torrance.
  • As a member of Golden State Dermatology, I look forward to streamlining administrative duties and channeling my focus and energies even more towards the patient care I enjoy so much," said Shirlene Jay, MD.
  • To learn more about Golden State Dermatology and their new partnership with Shirlene Jay, MD, please visit GoldenStateDermatology.com .
  • The founder of Golden State Dermatology, Edward Becker, MD said, "We're proud to support our clinicians to provide the highest-quality patient-centered care possible.

Most Effective Atopic Dermatitis Treatments May Also Be Most Harmful

Retrieved on: 
Wednesday, February 21, 2024

"Atopic dermatitis is the most common inflammatory skin condition with an increasing number of available systemic interventions.

Key Points: 
  • "Atopic dermatitis is the most common inflammatory skin condition with an increasing number of available systemic interventions.
  • Competing treatment options exist for atopic dermatitis, but uncertainty regarding their comparative effectiveness still remains, the study showed.
  • Researchers examined the benefits and harms of all systemic and phototherapy treatments for atopic dermatitis in this network meta-analysis.
  • In randomized, controlled trials addressing systemic and phototherapy treatments for atopic dermatitis from MEDLINE, EMBASE, CENTRAL, Web of Science and GREAT, researchers performed Bayesian random-effects network meta-analyses on atopic dermatitis severity, itch severity, sleep disturbance, quality of life, exacerbations and adverse events.

Evolved By Nature Announces Distribution Agreement with Barentz

Retrieved on: 
Wednesday, February 21, 2024

Distribution will be throughout the US and Canada.

Key Points: 
  • Distribution will be throughout the US and Canada.
  • "At Evolved By Nature, we understand that biotechnology is very exciting to the skincare, personal care and cosmetics industries – but that it's also looked at with some hesitation.
  • Biotech often engineers natural look-alike ingredients, which don't meet consumer demand for truly effective and sustainable ingredients.
  • We're proud to have developed a platform of natural ingredients using biotechnology to harvest the power of nature rather than attempting to mimic it in biosynthetic ways.

The Development of Allergic Disease Not Associated with Prenatal PM2.5 Air Pollution Exposure

Retrieved on: 
Friday, February 16, 2024

MILWAUKEE, Feb. 16, 2024 /PRNewswire-PRWeb/ -- No significant association was found between ambient particulate matter (PM2.5) exposure and incidences of asthma, allergic rhinitis or eczema according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting in Washington, DC this month.

Key Points: 
  • In settings of low overall air pollution levels, differences in the development of allergic disease by race were not significant in new birth cohort.
  • Black and Latin populations have been shown to have higher exposure to PM2.5 air pollution due to structural racism.
  • To assess the risks of prenatal air pollution exposure in minority populations, researchers recruited 1,261 mother-infant pairs from the University of Colorado.
  • The results found no evidence of an association between prenatal PM2.5 air pollution exposure and development of allergic disease or differences in air pollution exposure by race in a setting of low overall air pollution levels.

La Jolla Vein & Vascular Adds New Medical Specialty; Opens Dermatology Clinic in Vista

Retrieved on: 
Thursday, February 15, 2024

La Jolla Vein & Vascular adds new specialist to offer dermatology services in Vista.

Key Points: 
  • La Jolla Vein & Vascular adds new specialist to offer dermatology services in Vista.
  • The dermatology clinic is set to open in March, and is located at 906 Sycamore Ave, Suite 100, Vista, California.
  • View the full release here: https://www.businesswire.com/news/home/20240215088694/en/
    Dr. Heidi Busch, a board-certified dermatologist joins La Jolla Vein & Vascular to spearhead their expansion of services with a new Medical and Cosmetic Dermatology clinic in Vista, California.
  • To schedule a consultation with Dr. Busch, call 760-249-7007 or learn more about La Jolla Vein & Vascular’s services at www.ljvascular.com .

Ozone and PM2.5 Exposure is Associated with Nasal Key Driver Gene Expression in People with Asthma

Retrieved on: 
Thursday, February 15, 2024

MILWAUKEE, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Nasal key driver gene expression representing T-cell mediated immune processes is associated with ozone and fine particulate matter (PM2.5) exposure in people with asthma according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting.

Key Points: 
  • MILWAUKEE, Feb. 15, 2024 /PRNewswire-PRWeb/ -- Nasal key driver gene expression representing T-cell mediated immune processes is associated with ozone and fine particulate matter (PM2.5) exposure in people with asthma according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting.
  • In the study, researchers identified six key driver genes for ozone and three key driver genes for PM2.5 exposure.
  • FGL2, previously reported as a master regulator of asthma, was the most upstream key driver for both ozone and PM2.5.
  • The findings suggest exposure to ozone and PM2.5 in individuals with asthma is associated with nasal key driver gene expression representing T-cell mediated immune processes.

Bacteria in your gut can improve your mood − new research in mice tries to zero in on the crucial strains

Retrieved on: 
Thursday, February 15, 2024

But can they improve your mood, too?

Key Points: 
  • But can they improve your mood, too?
  • But the short answer, according to my team’s recently published research, is likely yes.
  • The beneficial bacteria in probiotics become part of a community of other microscopic organisms living in your digestive system called the gut microbiome.

Studying mood in mice

  • So how do you measure the mood of mice?
  • We exposed them to poop from either stressed mice or normal mice by sprinkling soiled bedding in their enclosures.
  • Microbes from the donor mice started to populate the gut microbiomes of the clean mice.
  • Within a few weeks, the clean mice exposed to poop from stressed mice started to develop stress- and anxiety-like behavior, even though nothing else had changed.

Which bacteria affect mood?

  • The results of our experiments led us back to our original question: Which bacteria can change your mood?
  • In our analysis, we found that a group of bacteria called Lactobacillus was greatly reduced in the stressed mice.
  • So we had to come up with a way to test how different strains affect anxious behavior.
  • Instead of tackling this colossal task alone, we created a method that other microbiome scientists can also use to look at this group of bacteria as systematically as possible.
  • To recreate the same experimental conditions for each species of microbe, we created a group of mice with only six species of bacteria in their microbiome, the bare minimum needed for normal and healthy development, which did not include Lactobacillus.

What’s next?

  • We hope that our research will open avenues for other scientists to test different probiotics.
  • In the meantime, give the Lactobacillus in your gut some love through a healthy, probiotics-rich diet.


Andrea Merchak has received funding from the National Institutes of Health (T32 NS115657, F31 AI174782).